Tilenka Thynne

ORCID: 0000-0003-4839-7716
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Pharmaceutical Practices and Patient Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Metabolism, Diabetes, and Cancer
  • Pharmaceutical studies and practices
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Antibiotics Pharmacokinetics and Efficacy
  • Cardiovascular Syncope and Autonomic Disorders
  • Primary Care and Health Outcomes
  • Pharmacology and Obesity Treatment
  • Potassium and Related Disorders
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Drug-Induced Hepatotoxicity and Protection
  • Pharmacological Effects and Toxicity Studies
  • Diabetes Management and Research
  • Diet and metabolism studies
  • Adrenal Hormones and Disorders
  • Gastroesophageal reflux and treatments
  • Psoriasis: Treatment and Pathogenesis
  • Cardiovascular Function and Risk Factors
  • Chronic Disease Management Strategies
  • Healthcare Policy and Management
  • Sympathectomy and Hyperhidrosis Treatments
  • Opioid Use Disorder Treatment

Flinders Medical Centre
2014-2025

Flinders University
2015-2025

Women's and Children's Health Network
2024

Royal Adelaide Hospital
2013-2014

Repatriation General Hospital
2013

American Pharmacists Association
2013

University of Otago
2013

Patients with Addison's disease (AD) report impaired subjective health status (SHS). Since cortisol exhibits a robust circadian cycle that entrains other biological clocks, SHS may be due to the noncircadian profile achieved conventional glucocorticoid replacement. Continuous subcutaneous hydrocortisone infusion (CSHI) reproduces profile, but its effects on have not been objectively evaluated.The aim of this study was determine effect CSHI in AD.This multicentre, double-blind,...

10.1210/jc.2014-2433 article EN The Journal of Clinical Endocrinology & Metabolism 2014-08-15

The aim of this study is to compare metrics specific for stress-induced hyperglycemia (SIH) with glucose predicting ischemic stroke outcome.This observational retrospective (n = 300) included patients acutely hospitalized over a 3.8-year period. We assessed the association between acute outcome stress ratio (SHR, relative increase in glycemia) and glycemic gap (GG, absolute using admission values 5-day maximum values, along incidence poor above recognized clinical thresholds 10 mmol/L, SHR...

10.1111/1753-0407.13223 article EN cc-by-nc Journal of Diabetes 2021-09-18

Background. Local health services make limited use of economic evaluation to inform decisions fund new service interventions. One barrier is the relevance published intervention effects local setting, given these can strongly reflect original context. Expert elicitation methods provide a structured approach explicitly and transparently adjust effect estimates, which then be used in local-level evaluations increase their relevance. was estimates for 2 interventions targeting prevention...

10.1177/23814683231226335 article EN cc-by-nc MDM Policy & Practice 2024-01-01

Objectives To investigate statin use and pain in people with cancer aged 70 to 79 80 older. Design Cross‐sectional. Setting Medical oncology outpatient clinic at the Royal Adelaide Hospital. Participants Individuals older who presented consecutively between January 2009 June 2010 (n = 385), of whom 106 were Measurements completed a structured data collection instrument, documenting medication use, comorbidities general assessment (10‐point visual analogue scale ( VAS )). Unadjusted adjusted...

10.1111/jgs.13051 article EN Journal of the American Geriatrics Society 2014-10-01

Factitious Cushing's syndrome is extremely rare. The diagnosis challenging as cross-reactivity of synthetic corticosteroids or their metabolites in immunoassay measurements plasma urinary cortisol can make distinguishing between true and factitious difficult. Adrenocorticotropin (ACTH) usually suppressed syndrome.A 54-year-old woman presented with clinical biochemical features an unsuppressed ACTH concentration. She denied recent exogenous corticosteroid use.Initial investigations revealed a...

10.1111/cen.12343 article EN Clinical Endocrinology 2013-10-12

Pharmacology of SGLT2 inhibitorsThe first two inhibitors approved in Australia, dapagliflozin and canagliflozin, have high bioavailability.They a half-life about 12 hours are taken once day.Dapagliflozin can be with or without food, while it is recommended that canagliflozin before the meal day.Both drugs highly protein bound plasma metabolised liver via glucuronidation.

10.18773/austprescr.2014.005 article EN cc-by-nc-nd Australian Prescriber 2013-11-26

Abstract Objectives Published evidence on health service interventions should inform decision-making in local services, but primary effectiveness studies and cost-effectiveness analyses are unlikely to reflect contexts other than those which the evaluations were undertaken. A ten-step framework was developed applied use published as basis for local-level economic that estimate expected costs effects of new intervention options specific contexts. Methods Working with a multidisciplinary group...

10.1017/s0266462323002775 article EN cc-by International Journal of Technology Assessment in Health Care 2023-01-01

Abstract Antiviral drugs were rapidly implemented into clinical practice for the treatment of high‐risk patients with COVID‐19, prompting development statewide guidelines. This South‐Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted inappropriate management relative drug–drug interactions dosing renal function. Additionally, it evaluated impact antiviral drug use suggested methods to improve quality medicines.

10.1111/imj.16254 article EN Internal Medicine Journal 2024-01-01

Therapeutic drug safety for Indigenous Australians: how do we close the gap?In setting of significant disease burden, lack data on Australia's population is concerning

10.5694/mja15.00937 article EN The Medical Journal of Australia 2016-01-01

Abstract Product information is often at odds with current evidence and guidelines inconsistent between products within classes. There no single ‘owner’ responsible for up‐to‐date medicines product information. Outdated increases the risk of inappropriate prescribing.

10.1111/imj.12295 article EN Internal Medicine Journal 2013-12-01

The aims of this study were to characterise the population pharmacokinetics metformin in patients receiving haemodialysis, and determine doses that will maintain median plasma concentrations below 5 mg L

10.1111/bcp.14244 article EN British Journal of Clinical Pharmacology 2020-02-15
Coming Soon ...